As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

Sanofi is continuing to splash the cash for autoimmune and immunology assets this spring by penning a new deal with ...

Just a few months after raising $200 million in third-round financing, immunology specialist Zenas ... acceleration in the number of biotech companies seeking public listings after a two-year ...

Sanofi is teaming up with a private biotech in Delaware on a pair of bispecific antibodies for autoimmune and inflammatory ...

China is teeming with promising science in areas such as oncology and immunology ... comes not only from other VC firms or even biotech companies. It’s coming from big pharma, he said.

The number of smid-cap biotech companies with market caps at or below ... Pfizer is launching several potential blockbusters in cancer and immunology. Data on Pfizer’s obesity-drug candidate ...

Companies like Celgene, Biogen Idec, and Gilead Sciences all took top spots on our list of the Best Employers in America. Clearly there are a lot of people who love working in pharma and biotech ...

AbbVie and Anima Biotech have announced that they are collaborating ... that modulate mRNA biology for three targets in cancer and immunology. Anima uses its mRNA Lightning platform to discover ...

A number of biotech companies are looking to supplement plant-derived fragrances by engineering bacteria and yeast to produce commercial scents, potentially changing how the industry sources its ...

Room 314 Presenter: Andrea Sant, Ph.D., Professor of Microbiology and Immunology at the University of Rochester Medical Center Separately, PDS Biotech announced that, due to new U.S. National ...

The global expansion of Chinese biotech companies accelerated in the first ... multi-specific antibodies for immunology and oncology. The deal was valued at US$4.7 billion, according to DrugTimes.